about
Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditionsActivation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharideSterile post-traumatic immunosuppressionChemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte traffickingMonomeric solution structure of the prototypical 'C' chemokine lymphotactinExpression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligandsThe spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interactionCCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infectionAn investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.Antiviral potential of chemokines.Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21.L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis.CXCL16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gamma interferon production.In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue.Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.Mitochondrial damage-associated molecular patterns released by abdominal trauma suppress pulmonary immune responsesEnhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coliThe stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas.Evaluation of chemokines in gingival crevicular fluid in children with band and loop space maintainers: A clinico-biochemical study.Effects of interleukin-1β and tumor necrosis factor-α on macrophage inflammatory protein-3α production in synovial fibroblast-like cells from human temporomandibular jointsRole of the innate immunity in female reproductive tract.Finding their niche: chemokines directing cell migration in the thymus.Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease.Characterization of the stromal cell-derived factor-1alpha-heparin complex.Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells.Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.Human neutrophils as a source of nociceptin: a novel link between pain and inflammation.The Role of the Chemokine System in Tissue Response to Prosthetic By-products Leading to Periprosthetic Osteolysis and Aseptic Loosening.CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis.Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis.C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis.The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes.CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse.Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonist.CK12a, a CCL19-like Chemokine That Orchestrates both Nasal and Systemic Antiviral Immune Responses in Rainbow Trout.Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice.Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20.
P2860
Q24292437-3B5AAD4C-3D00-4063-ADD2-B8E93A395E2FQ24538617-000DE037-AB3A-40F6-847D-BEFF8E6E8DC5Q26748401-9F55BC92-92AB-445B-93E1-0B571E48E542Q27013008-A4CE3E13-C55D-4D6C-84E2-4789603D8A12Q27635401-58371C11-6A9B-4AAC-8291-25AEB440E01FQ28583515-0657A391-3A45-4B01-B32B-D5DA840A6F9CQ28972215-7493E7D3-F792-4D7E-B21B-BC95150FDAEEQ31032605-D7E5CA66-13B5-4873-998B-D0E043786807Q33252011-BDD9AF04-1BA5-495B-BEB2-C69AB9548FA8Q33359767-E58AC0A2-88AA-43DB-8BBA-13FCEB33C85DQ34243584-E4A1A1F1-DCB9-452D-99D0-26F8B8715B7FQ34382573-4D56D1BE-9FDB-493A-A2E3-D1572AB5ECFEQ34491859-B53F8ADC-A5B8-47D0-9CEB-BD1B5A924473Q35049150-4E1D74A6-9D11-4A1E-AF34-3BDA3DFE1BF8Q35220363-E4CC544C-50EF-4D2F-BF64-9E07F3F684FFQ35745538-5B7FE72C-5C7C-446F-A6C8-08323DD48E9DQ35746460-E870617D-B91C-41E8-9B6F-200CC432010CQ35912505-89123712-399D-4226-B7E6-AD9F45CA4153Q36044254-165C7ED4-D0AA-400E-9778-421D7592604BQ36324858-401173E8-49BD-44A5-8BC2-3371BDE992EBQ37216607-A3D2E414-3884-48BA-B223-DA83390C9438Q37261899-A5DD600F-7240-4BB7-A53F-3AD8A5A79B78Q37592611-E49EB731-CA60-42AF-86BD-B3B964A9F5ABQ37816936-18B8974C-A229-4ACF-AA8D-613A67B3EA7BQ38079237-EE36AA5B-B776-4330-8B5F-73089527421FQ38306497-C0F739A3-1E5F-40F4-8FB0-C01BE015CE6EQ40371413-A797B365-01E1-40BD-8DE6-22BE27A281B5Q40584252-937A1568-798B-4F81-842C-5959FFD52947Q40900896-E07E1FCB-E33F-4DA9-80F0-A813C0088E85Q41537137-91B2928D-34B2-4BF8-B777-CE2B3096FDCCQ41883527-42483966-BD96-4C97-9B85-89062DA2B447Q42476082-5754A6FB-E49C-4EB8-BF65-2357A9FCDB7DQ42635450-0CF4CE83-F314-440F-8408-00398F317FC6Q44159142-EBF1B40F-533F-429F-834D-165877001499Q44729731-D9D20359-3206-4A2B-AF50-565C07276C6BQ45748156-8B07D876-6638-441E-8195-B0EA35A37C8AQ47253731-F4E4647A-2F32-45D9-9618-92A20492E88FQ47603368-65C8CC2A-89A4-4572-9C4C-1940B0B1B912Q48691634-C68B2E14-7B07-4A92-91A7-F868E60E725AQ50096567-6697F57E-5CF9-49C0-BA2B-3D8F47330538
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chemokines: extracellular messengers for all occasions?
@ast
Chemokines: extracellular messengers for all occasions?
@en
Chemokines: extracellular messengers for all occasions?
@nl
type
label
Chemokines: extracellular messengers for all occasions?
@ast
Chemokines: extracellular messengers for all occasions?
@en
Chemokines: extracellular messengers for all occasions?
@nl
prefLabel
Chemokines: extracellular messengers for all occasions?
@ast
Chemokines: extracellular messengers for all occasions?
@en
Chemokines: extracellular messengers for all occasions?
@nl
P2860
P1433
P1476
Chemokines: extracellular messengers for all occasions?
@en
P2093
P2860
P356
10.1002/(SICI)1521-1878(199901)21:1<17::AID-BIES3>3.0.CO;2-4
P407
P577
1999-01-01T00:00:00Z